Apple (AAPL) 10-Q 31 Jan 25 2025 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares shares in Thousands	3 Months Ended
	Dec. 28, 2024	Jan. 17, 2025
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 28, 2024
Document Transition Report	false
Entity File Number	001-36743
Entity Registrant Name	Apple Inc.
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	94-2404110
Entity Address, Address Line One	One Apple Park Way
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	996-1010
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		15,022,073
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000320193
Current Fiscal Year End Date	--09-27
Common Stock, $0.00001 par value per share
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $0.00001 par value per share
Trading Symbol	AAPL
Security Exchange Name	NASDAQ
0.000% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.000% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.875% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.625% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	1.625% Notes due 2026
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
2.000% Notes due 2027
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2027
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.375% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.050% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	3.050% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.500% Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2031
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.600% Notes due 2042
Entity Information [Line Items]
Title of 12(b) Security	3.600% Notes due 2042
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Net sales	$ 124,300	$ 119,575
Cost of sales	66,025	64,720
Gross margin	58,275	54,855
Operating expenses:
Research and development	8,268	7,696
Selling, general and administrative	7,175	6,786
Total operating expenses	15,443	14,482
Operating income	42,832	40,373
Other income/(expense), net	(248)	(50)
Income before provision for income taxes	42,584	40,323
Provision for income taxes	6,254	6,407
Net income	$ 36,330	$ 33,916
Earnings per share:
Basic (in dollars per share)	$ 2.41	$ 2.19
Diluted (in dollars per share)	$ 2.40	$ 2.18
Shares used in computing earnings per share:
Basic (in shares)	15,081,724	15,509,763
Diluted (in shares)	15,150,865	15,576,641
Products
Net sales	$ 97,960	$ 96,458
Cost of sales	59,447	58,440
Services
Net sales	26,340	23,117
Cost of sales	$ 6,578	$ 6,280

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 36,330	$ 33,916
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax	(625)	308
Change in unrealized gains/losses on derivative instruments, net of tax:
Change in fair value of derivative instruments	1,651
Change in fair value of derivative instruments		(531)
Adjustment for net (gains)/losses realized and included in net income	784
Adjustment for net (gains)/losses realized and included in net income		(823)
Total change in unrealized gains/losses on derivative instruments	2,435
Total change in unrealized gains/losses on derivative instruments		(1,354)
Change in unrealized gains/losses on marketable debt securities, net of tax:
Change in fair value of marketable debt securities	(1,647)	3,045
Adjustment for net (gains)/losses realized and included in net income	220	75
Total change in unrealized gains/losses on marketable debt securities	(1,427)	3,120
Total other comprehensive income	383	2,074
Total comprehensive income	$ 36,713	$ 35,990

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) shares in Thousands, $ in Millions	Dec. 28, 2024	Sep. 28, 2024
Current assets:
Cash and cash equivalents	$ 30,299	$ 29,943
Marketable securities	23,476	35,228
Accounts receivable, net	29,639	33,410
Vendor non-trade receivables	29,667	32,833
Inventories	6,911	7,286
Other current assets	13,248	14,287
Total current assets	133,240	152,987
Non-current assets:
Marketable securities	87,593	91,479
Property, plant and equipment, net	46,069	45,680
Other non-current assets	77,183	74,834
Total non-current assets	210,845	211,993
Total assets	344,085	364,980
Current liabilities:
Accounts payable	61,910	68,960
Other current liabilities	61,151	78,304
Deferred revenue	8,461	8,249
Commercial paper	1,995	9,967
Term debt	10,848	10,912
Total current liabilities	144,365	176,392
Non-current liabilities:
Term debt	83,956	85,750
Other non-current liabilities	49,006	45,888
Total non-current liabilities	132,962	131,638
Total liabilities	277,327	308,030
Commitments and contingencies
Common stock, shares outstanding (in shares)	15,040,731	15,116,786
Common stock, shares issued (in shares)	15,040,731	15,116,786
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,040,731 and 15,116,786 shares issued and outstanding, respectively	$ 84,768	$ 83,276
Accumulated deficit	(11,221)	(19,154)
Accumulated other comprehensive loss	(6,789)	(7,172)
Total shareholders’ equity	66,758	56,950
Total liabilities and shareholders’ equity	$ 344,085	$ 364,980

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Dec. 28, 2024	Sep. 28, 2024
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	50,400,000,000	50,400,000,000
Common stock, shares issued (in shares)	15,040,731,000	15,116,786,000
Common stock, shares outstanding (in shares)	15,040,731,000	15,116,786,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common stock and additional paid-in capital	Retained earnings/(Accumulated deficit)	Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 30, 2023	$ 62,146	$ 73,812	$ (214)	$ (11,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards		(1,660)	(1,018)
Share-based compensation		3,084
Net income	33,916		33,916
Dividends and dividend equivalents declared			(3,774)
Common stock repurchased			(20,668)
Other comprehensive income	2,074			2,074
Ending balances at Dec. 30, 2023	$ 74,100	75,236	8,242	(9,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.24
Beginning balances at Sep. 28, 2024	$ 56,950	83,276	(19,154)	(7,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock withheld related to net share settlement of equity awards		(1,891)	(1,102)
Share-based compensation		3,383
Net income	36,330		36,330
Dividends and dividend equivalents declared			(3,819)
Common stock repurchased	(23,300)		(23,476)
Other comprehensive income	383			383
Ending balances at Dec. 28, 2024	$ 66,758	$ 84,768	$ (11,221)	$ (6,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.25

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Statement of Cash Flows [Abstract]
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances	$ 29,943	$ 30,737
Operating activities:
Net income	36,330	33,916
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization	3,080	2,848
Share-based compensation expense	3,286	2,997
Other	(2,009)	(989)
Changes in operating assets and liabilities:
Accounts receivable, net	3,597	6,555
Vendor non-trade receivables	3,166	4,569
Inventories	215	(137)
Other current and non-current assets	939	(1,457)
Accounts payable	(6,671)	(4,542)
Other current and non-current liabilities	(11,998)	(3,865)
Cash generated by operating activities	29,935	39,895
Investing activities:
Purchases of marketable securities	(6,124)	(9,780)
Proceeds from maturities of marketable securities	15,967	13,046
Proceeds from sales of marketable securities	3,492	1,337
Payments for acquisition of property, plant and equipment	(2,940)	(2,392)
Other	(603)	(284)
Cash generated by investing activities	9,792	1,927
Financing activities:
Payments for taxes related to net share settlement of equity awards	(2,921)	(2,591)
Payments for dividends and dividend equivalents	(3,856)	(3,825)
Repurchases of common stock	(23,606)	(20,139)
Repayments of term debt	(1,009)	0
Repayments of commercial paper, net	(7,944)	(3,984)
Other	(35)	(46)
Cash used in financing activities	(39,371)	(30,585)
Increase in cash, cash equivalents, and restricted cash and cash equivalents	356	11,237
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances	30,299	41,974
Supplemental cash flow disclosure:
Cash paid for income taxes, net	$ 18,651	$ 7,255

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 28, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (the “2024 Form 10-K”). The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2025 and 2024 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.

Revenue

Revenue	3 Months Ended
	Dec. 28, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Net sales disaggregated by significant products and services for the three months ended December 28, 2024 and December 30, 2023 were as follows (in millions): Three Months Ended December 28, December 30, iPhone ® $ 69,138 $ 69,702 Mac ® 8,987 7,780 iPad ® 8,088 7,023 Wearables, Home and Accessories 11,747 11,953 Services 26,340 23,117 Total net sales $ 124,300 $ 119,575 Total net sales include $3.7 billion of revenue recognized in the three months ended December 28, 2024 that was included in deferred revenue as of September 28, 2024 and $3.5 billion of revenue recognized in the three months ended December 30, 2023 that was included in deferred revenue as of September 30, 2023. The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, “Segment Information and Geographic Data” for the three months ended December 28, 2024 and December 30, 2023, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales. As of December 28, 2024 and September 28, 2024, the Company had total deferred revenue of $13.2 billion and $12.8 billion, respectively. As of December 28, 2024, the Company expects 64% of total deferred revenue to be realized in less than a year, 25% within one-to-two years, 9% within two-to-three years and 2% in greater than three years.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table shows the computation of basic and diluted earnings per share for the three months ended December 28, 2024 and December 30, 2023 (net income in millions and shares in thousands): Three Months Ended December 28, December 30, Numerator: Net income $ 36,330 $ 33,916 Denominator: Weighted-average basic shares outstanding 15,081,724 15,509,763 Effect of dilutive share-based awards 69,141 66,878 Weighted-average diluted shares 15,150,865 15,576,641 Basic earnings per share $ 2.41 $ 2.19 Diluted earnings per share $ 2.40 $ 2.18

Financial Instruments

Financial Instruments	3 Months Ended
	Dec. 28, 2024
Financial Instruments [Abstract]
Financial Instruments	Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 28, 2024 and September 28, 2024 (in millions): December 28, 2024 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 27,073 $ — $ — $ 27,073 $ 27,073 $ — $ — Level 1: Money market funds 937 — — 937 937 — — Mutual funds 597 109 (7) 699 — 699 — Subtotal 1,534 109 (7) 1,636 937 699 — Level 2 (1) : U.S. Treasury securities 15,516 5 (616) 14,905 903 2,718 11,284 U.S. agency securities 5,570 — (303) 5,267 314 1,683 3,270 Non-U.S. government securities 8,596 22 (819) 7,799 50 2,524 5,225 Certificates of deposit and time deposits 1,147 — (13) 1,134 874 247 13 Commercial paper 418 — (19) 399 101 298 — Corporate debt securities 61,566 96 (2,210) 59,452 47 14,451 44,954 Municipal securities 355 — (7) 348 — 189 159 Mortgage- and asset-backed securities 25,313 29 (1,987) 23,355 — 667 22,688 Subtotal 118,481 152 (5,974) 112,659 2,289 22,777 87,593 Total (2)(3) $ 147,088 $ 261 $ (5,981) $ 141,368 $ 30,299 $ 23,476 $ 87,593 September 28, 2024 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 27,199 $ — $ — $ 27,199 $ 27,199 $ — $ — Level 1: Money market funds 778 — — 778 778 — — Mutual funds 515 105 (3) 617 — 617 — Subtotal 1,293 105 (3) 1,395 778 617 — Level 2 (1) : U.S. Treasury securities 16,150 45 (516) 15,679 212 4,087 11,380 U.S. agency securities 5,431 — (272) 5,159 155 703 4,301 Non-U.S. government securities 17,959 93 (484) 17,568 1,158 10,810 5,600 Certificates of deposit and time deposits 873 — — 873 387 478 8 Commercial paper 1,066 — — 1,066 28 1,038 — Corporate debt securities 65,622 270 (1,953) 63,939 26 16,027 47,886 Municipal securities 412 — (7) 405 — 190 215 Mortgage- and asset-backed securities 24,595 175 (1,403) 23,367 — 1,278 22,089 Subtotal 132,108 583 (4,635) 128,056 1,966 34,611 91,479 Total (2)(3) $ 160,600 $ 688 $ (4,638) $ 156,650 $ 29,943 $ 35,228 $ 91,479 (1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. (2) As of December 28, 2024 and September 28, 2024, cash and cash equivalents included $126 million and $2.6 billion, respectively, held in escrow and restricted from general use. These restricted cash and cash equivalents are designated to settle the Company’s obligation related to the 2016 European Commission (the “Commission”) decision that Ireland granted state aid to the Company (the “State Aid Decision”), which was confirmed during the fourth quarter of 2024 by the European Court of Justice in a reversal of the 2020 judgment of the European General Court. (3) As of December 28, 2024 and September 28, 2024, current marketable securities included $3.3 billion and $13.2 billion, respectively, held in escrow and restricted from general use. These restricted marketable securities are designated to settle the Company’s obligation related to the State Aid Decision. As of December 28, 2024, 85% of the Company’s non-current marketable debt securities other than mortgage- and asset-backed securities had maturities between 1 and 5 years, 11% between 5 and 10 years, and 4% greater than 10 years. As of December 28, 2024, 13% of the Company’s non-current mortgage- and asset-backed securities had maturities between 1 and 5 years, 10% between 5 and 10 years, and 77% greater than 10 years. Derivative Instruments and Hedging The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates. Foreign Exchange Rate Risk To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of December 28, 2024, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 18 years. The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. Interest Rate Risk To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges. The notional amounts of the Company’s outstanding derivative instruments as of December 28, 2024 and September 28, 2024 were as follows (in millions): December 28, September 28, Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 47,466 $ 64,069 Interest rate contracts $ 14,575 $ 14,575 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 96,150 $ 91,493 As of December 28, 2024 and September 28, 2024, the carrying amount of the Company’s current and non-current term debt subject to fair value hedges was $13.3 billion and $13.5 billion, respectively. Accounts Receivable Trade Receivables As of December 28, 2024, the Company had two customers that individually represented 10% or more of total trade receivables, which accounted for 18% and 11%. The Company’s third-party cellular network carriers accounted for 33% and 38% of total trade receivables as of December 28, 2024 and September 28, 2024, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk. Vendor Non-Trade Receivables The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of December 28, 2024, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted f or 43% and 24% . A s of September 28, 2024, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 44% and 23%.

Condensed Consolidated Financia

Condensed Consolidated Financial Statement Details	3 Months Ended
	Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Financial Statement Details	Condensed Consolidated Financial Statement Details The following tables show the Company’s condensed consolidated financial statement details as of December 28, 2024 and September 28, 2024 (in millions): Inventories December 28, September 28, Components $ 2,792 $ 3,627 Finished goods 4,119 3,659 Total inventories $ 6,911 $ 7,286 Property, Plant and Equipment, Net December 28, September 28, Gross property, plant and equipment $ 120,615 $ 119,128 Accumulated depreciation (74,546) (73,448) Total property, plant and equipment, net $ 46,069 $ 45,680

Debt

Debt	3 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
Debt	Debt Commercial Paper The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of December 28, 2024 and September 28, 2024, the Company had $2.0 billion and $10.0 billion of commercial paper outstanding, respectively. Term Debt As of December 28, 2024 and September 28, 2024, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $94.8 billion and $96.7 billion, respectively (collectively the “Notes”). As of December 28, 2024 and September 28, 2024, the fair value of the Company’s Notes, based on Level 2 inputs, was $82.7 billion and $88.4 billion, respectively.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Dec. 28, 2024
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchase Program During the three months ended December 28, 2024, the Company repurchased 100 million shares of its common stock for $23.3 billion. The Company’s share repurchase program does not obligate the Company to acquire a minimum amount of shares. Under the program, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Restricted Stock Units A summary of the Company’s RSU activity and related information for the three months ended December 28, 2024 is as follows: Number of RSUs (in thousands) Weighted-Average Balance as of September 28, 2024 163,326 $ 158.73 RSUs granted 61,391 $ 228.04 RSUs vested (35,683) $ 147.36 RSUs canceled (2,278) $ 174.77 Balance as of December 28, 2024 186,756 $ 183.49 The total vesting-date fair value of RSUs was $8.4 billion and $7.7 billion for the three months ended December 28, 2024 and December 30, 2023, respectively. Share-Based Compensation The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2024 and December 30, 2023 (in millions): Three Months Ended December 28, December 30, Share-based compensation expense $ 3,286 $ 2,997 Income tax benefit related to share-based compensation expense $ (1,332) $ (1,235) As of December 28, 2024, the total unrecognized compensation cost related to outstanding RSUs was $29.2 billion, which the Company expects to recognize over a weighted-average period of 2.9 years.

Contingencies

Contingencies	3 Months Ended
	Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.

Segment Information and Geograp

Segment Information and Geographic Data	3 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Segment Information and Geographic Data	Segment Information and Geographic Data The following table shows information by reportable segment for the three months ended December 28, 2024 and December 30, 2023 (in millions): Three Months Ended December 28, December 30, Americas: Net sales $ 52,648 $ 50,430 Operating income $ 21,509 $ 20,357 Europe: Net sales $ 33,861 $ 30,397 Operating income $ 14,607 $ 12,711 Greater China: Net sales $ 18,513 $ 20,819 Operating income $ 8,160 $ 8,622 Japan: Net sales $ 8,987 $ 7,767 Operating income $ 4,314 $ 3,819 Rest of Asia Pacific: Net sales $ 10,291 $ 10,162 Operating income $ 4,584 $ 4,579 A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 28, 2024 and December 30, 2023 is as follows (in millions): Three Months Ended December 28, December 30, Segment operating income $ 53,174 $ 50,088 Research and development expense (8,268) (7,696) Other corporate expenses, net (2,074) (2,019) Total operating income $ 42,832 $ 40,373

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Pay vs Performance Disclosure
Net income	$ 36,330	$ 33,916

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 28, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Luca Maestri [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On November 6, 2024, Luca Maestri, the Company’s former Senior Vice President and Chief Financial Officer, and current Vice President, Corporate Services, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the sale, subject to certain price limits, of shares vesting between April 1, 2025 and October 15, 2025, pursuant to certain equity awards granted to Mr. Maestri, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. Mr. Maestri’s plan will expire on December 31, 2025, subject to early termination in accordance with the terms of the plan.
Name	Luca Maestri
Title	former Senior Vice President and Chief Financial Officer, and current Vice President, Corporate Services
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 6, 2024
Expiration Date	December 31, 2025
Arrangement Duration	421 days
Kate Adams [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On November 25, 2024, Kate Adams, the Company’s Senior Vice President, General Counsel and Secretary, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the sale of shares vesting between April 1, 2025 and October 1, 2025, pursuant to certain equity awards granted to Ms. Adams, excluding any shares withheld by the Company to satisfy income tax withholding and remittance obligations. Ms. Adam’s plan will expire on November 1, 2025, subject to early termination in accordance with the terms of the plan.
Name	Kate Adams
Title	Senior Vice President, General Counsel and Secretary
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 25, 2024
Expiration Date	November 1, 2025
Arrangement Duration	342 days

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 28, 2024
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (the “2024 Form 10-K”).
Fiscal Period	The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2025 and 2024 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements	The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Dec. 28, 2024
Revenue from Contract with Customer [Abstract]
Net Sales Disaggregated by Significant Products and Services	Net sales disaggregated by significant products and services for the three months ended December 28, 2024 and December 30, 2023 were as follows (in millions): Three Months Ended December 28, December 30, iPhone ® $ 69,138 $ 69,702 Mac ® 8,987 7,780 iPad ® 8,088 7,023 Wearables, Home and Accessories 11,747 11,953 Services 26,340 23,117 Total net sales $ 124,300 $ 119,575

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table shows the computation of basic and diluted earnings per share for the three months ended December 28, 2024 and December 30, 2023 (net income in millions and shares in thousands): Three Months Ended December 28, December 30, Numerator: Net income $ 36,330 $ 33,916 Denominator: Weighted-average basic shares outstanding 15,081,724 15,509,763 Effect of dilutive share-based awards 69,141 66,878 Weighted-average diluted shares 15,150,865 15,576,641 Basic earnings per share $ 2.41 $ 2.19 Diluted earnings per share $ 2.40 $ 2.18

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Dec. 28, 2024
Financial Instruments [Abstract]
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category	The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 28, 2024 and September 28, 2024 (in millions): December 28, 2024 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 27,073 $ — $ — $ 27,073 $ 27,073 $ — $ — Level 1: Money market funds 937 — — 937 937 — — Mutual funds 597 109 (7) 699 — 699 — Subtotal 1,534 109 (7) 1,636 937 699 — Level 2 (1) : U.S. Treasury securities 15,516 5 (616) 14,905 903 2,718 11,284 U.S. agency securities 5,570 — (303) 5,267 314 1,683 3,270 Non-U.S. government securities 8,596 22 (819) 7,799 50 2,524 5,225 Certificates of deposit and time deposits 1,147 — (13) 1,134 874 247 13 Commercial paper 418 — (19) 399 101 298 — Corporate debt securities 61,566 96 (2,210) 59,452 47 14,451 44,954 Municipal securities 355 — (7) 348 — 189 159 Mortgage- and asset-backed securities 25,313 29 (1,987) 23,355 — 667 22,688 Subtotal 118,481 152 (5,974) 112,659 2,289 22,777 87,593 Total (2)(3) $ 147,088 $ 261 $ (5,981) $ 141,368 $ 30,299 $ 23,476 $ 87,593 September 28, 2024 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 27,199 $ — $ — $ 27,199 $ 27,199 $ — $ — Level 1: Money market funds 778 — — 778 778 — — Mutual funds 515 105 (3) 617 — 617 — Subtotal 1,293 105 (3) 1,395 778 617 — Level 2 (1) : U.S. Treasury securities 16,150 45 (516) 15,679 212 4,087 11,380 U.S. agency securities 5,431 — (272) 5,159 155 703 4,301 Non-U.S. government securities 17,959 93 (484) 17,568 1,158 10,810 5,600 Certificates of deposit and time deposits 873 — — 873 387 478 8 Commercial paper 1,066 — — 1,066 28 1,038 — Corporate debt securities 65,622 270 (1,953) 63,939 26 16,027 47,886 Municipal securities 412 — (7) 405 — 190 215 Mortgage- and asset-backed securities 24,595 175 (1,403) 23,367 — 1,278 22,089 Subtotal 132,108 583 (4,635) 128,056 1,966 34,611 91,479 Total (2)(3) $ 160,600 $ 688 $ (4,638) $ 156,650 $ 29,943 $ 35,228 $ 91,479 (1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. (2) As of December 28, 2024 and September 28, 2024, cash and cash equivalents included $126 million and $2.6 billion, respectively, held in escrow and restricted from general use. These restricted cash and cash equivalents are designated to settle the Company’s obligation related to the 2016 European Commission (the “Commission”) decision that Ireland granted state aid to the Company (the “State Aid Decision”), which was confirmed during the fourth quarter of 2024 by the European Court of Justice in a reversal of the 2020 judgment of the European General Court. (3) As of December 28, 2024 and September 28, 2024, current marketable securities included $3.3 billion and $13.2 billion, respectively, held in escrow and restricted from general use. These restricted marketable securities are designated to settle the Company’s obligation related to the State Aid Decision.
Notional Amounts of Outstanding Derivative Instruments	The notional amounts of the Company’s outstanding derivative instruments as of December 28, 2024 and September 28, 2024 were as follows (in millions): December 28, September 28, Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 47,466 $ 64,069 Interest rate contracts $ 14,575 $ 14,575 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 96,150 $ 91,493

Condensed Consolidated Financ_2

Condensed Consolidated Financial Statement Details (Tables)	3 Months Ended
	Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Inventories	Inventories December 28, September 28, Components $ 2,792 $ 3,627 Finished goods 4,119 3,659 Total inventories $ 6,911 $ 7,286
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net December 28, September 28, Gross property, plant and equipment $ 120,615 $ 119,128 Accumulated depreciation (74,546) (73,448) Total property, plant and equipment, net $ 46,069 $ 45,680

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]
Restricted Stock Unit Activity	A summary of the Company’s RSU activity and related information for the three months ended December 28, 2024 is as follows: Number of RSUs (in thousands) Weighted-Average Balance as of September 28, 2024 163,326 $ 158.73 RSUs granted 61,391 $ 228.04 RSUs vested (35,683) $ 147.36 RSUs canceled (2,278) $ 174.77 Balance as of December 28, 2024 186,756 $ 183.49
Summary of Share-Based Compensation Expense and the Related Income Tax Benefit	The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three months ended December 28, 2024 and December 30, 2023 (in millions): Three Months Ended December 28, December 30, Share-based compensation expense $ 3,286 $ 2,997 Income tax benefit related to share-based compensation expense $ (1,332) $ (1,235)

Segment Information and Geogr_2

Segment Information and Geographic Data (Tables)	3 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Information by Reportable Segment	The following table shows information by reportable segment for the three months ended December 28, 2024 and December 30, 2023 (in millions): Three Months Ended December 28, December 30, Americas: Net sales $ 52,648 $ 50,430 Operating income $ 21,509 $ 20,357 Europe: Net sales $ 33,861 $ 30,397 Operating income $ 14,607 $ 12,711 Greater China: Net sales $ 18,513 $ 20,819 Operating income $ 8,160 $ 8,622 Japan: Net sales $ 8,987 $ 7,767 Operating income $ 4,314 $ 3,819 Rest of Asia Pacific: Net sales $ 10,291 $ 10,162 Operating income $ 4,584 $ 4,579
Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations	A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 28, 2024 and December 30, 2023 is as follows (in millions): Three Months Ended December 28, December 30, Segment operating income $ 53,174 $ 50,088 Research and development expense (8,268) (7,696) Other corporate expenses, net (2,074) (2,019) Total operating income $ 42,832 $ 40,373

Revenue - Net Sales Disaggregat

Revenue - Net Sales Disaggregated by Significant Products and Services (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 124,300	$ 119,575
iPhone
Disaggregation of Revenue [Line Items]
Net sales	69,138	69,702
Mac
Disaggregation of Revenue [Line Items]
Net sales	8,987	7,780
iPad
Disaggregation of Revenue [Line Items]
Net sales	8,088	7,023
Wearables, Home and Accessories
Disaggregation of Revenue [Line Items]
Net sales	11,747	11,953
Services
Disaggregation of Revenue [Line Items]
Net sales	$ 26,340	$ 23,117

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Billions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Sep. 28, 2024
Revenue from Contract with Customer [Abstract]
Revenue recognized that was included in deferred revenue at the beginning of the period	$ 3.7	$ 3.5
Total deferred revenue	$ 13.2		$ 12.8

Revenue - Deferred Revenue, Exp

Revenue - Deferred Revenue, Expected Timing of Realization (Details)	Dec. 28, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-12-29
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	64%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-12-28
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	25%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-12-27
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	9%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-12-26
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	2%
Deferred revenue, expected timing of realization, period	1 year

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Numerator:
Net income	$ 36,330	$ 33,916
Denominator:
Weighted-average basic shares outstanding (in shares)	15,081,724	15,509,763
Effect of dilutive share-based awards (in shares)	69,141	66,878
Weighted-average diluted shares (in shares)	15,150,865	15,576,641
Basic earnings per share (in dollars per share)	$ 2.41	$ 2.19
Diluted earnings per share (in dollars per share)	$ 2.40	$ 2.18

Financial Instruments - Cash, C

Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions	Dec. 28, 2024	Sep. 28, 2024
Marketable Securities [Line Items]
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost	$ 147,088	$ 160,600
Cash Equivalents and Marketable Securities, Unrealized Gains	261	688
Cash Equivalents and Marketable Securities, Unrealized Losses	(5,981)	(4,638)
Cash, Cash Equivalents and Marketable Securities, Fair Value	141,368	156,650
Cash and Cash Equivalents	30,299	29,943
Current Marketable Securities	23,476	35,228
Non-Current Marketable Securities	87,593	91,479
Unfavorable investigation outcome, EU State Aid rules
Marketable Securities [Line Items]
Cash and cash equivalents held in escrow and restricted from general use	126	2,600
Current marketable securities held in escrow and restricted from general use	3,300	13,200
Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	1,534	1,293
Marketable Securities, Equity, Unrealized Gains	109	105
Marketable Securities, Equity, Unrealized Losses	(7)	(3)
Marketable Securities, Equity, Fair Value	1,636	1,395
Cash and Cash Equivalents	937	778
Current Marketable Securities	699	617
Non-Current Marketable Securities	0	0
Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	118,481	132,108
Marketable Securities, Debt, Unrealized Gains	152	583
Marketable Securities, Debt, Unrealized Losses	(5,974)	(4,635)
Marketable Securities, Debt, Fair Value	112,659	128,056
Cash and Cash Equivalents	2,289	1,966
Current Marketable Securities	22,777	34,611
Non-Current Marketable Securities	87,593	91,479
Cash
Marketable Securities [Line Items]
Cash	27,073	27,199
Cash and Cash Equivalents	27,073	27,199
Money market funds | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	937	778
Marketable Securities, Equity, Unrealized Gains	0	0
Marketable Securities, Equity, Unrealized Losses	0	0
Marketable Securities, Equity, Fair Value	937	778
Cash and Cash Equivalents	937	778
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Mutual funds | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	597	515
Marketable Securities, Equity, Unrealized Gains	109	105
Marketable Securities, Equity, Unrealized Losses	(7)	(3)
Marketable Securities, Equity, Fair Value	699	617
Cash and Cash Equivalents	0	0
Current Marketable Securities	699	617
Non-Current Marketable Securities	0	0
U.S. Treasury securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	15,516	16,150
Marketable Securities, Debt, Unrealized Gains	5	45
Marketable Securities, Debt, Unrealized Losses	(616)	(516)
Marketable Securities, Debt, Fair Value	14,905	15,679
Cash and Cash Equivalents	903	212
Current Marketable Securities	2,718	4,087
Non-Current Marketable Securities	11,284	11,380
U.S. agency securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	5,570	5,431
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(303)	(272)
Marketable Securities, Debt, Fair Value	5,267	5,159
Cash and Cash Equivalents	314	155
Current Marketable Securities	1,683	703
Non-Current Marketable Securities	3,270	4,301
Non-U.S. government securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	8,596	17,959
Marketable Securities, Debt, Unrealized Gains	22	93
Marketable Securities, Debt, Unrealized Losses	(819)	(484)
Marketable Securities, Debt, Fair Value	7,799	17,568
Cash and Cash Equivalents	50	1,158
Current Marketable Securities	2,524	10,810
Non-Current Marketable Securities	5,225	5,600
Certificates of deposit and time deposits | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	1,147	873
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(13)	0
Marketable Securities, Debt, Fair Value	1,134	873
Cash and Cash Equivalents	874	387
Current Marketable Securities	247	478
Non-Current Marketable Securities	13	8
Commercial paper | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	418	1,066
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(19)	0
Marketable Securities, Debt, Fair Value	399	1,066
Cash and Cash Equivalents	101	28
Current Marketable Securities	298	1,038
Non-Current Marketable Securities	0	0
Corporate debt securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	61,566	65,622
Marketable Securities, Debt, Unrealized Gains	96	270
Marketable Securities, Debt, Unrealized Losses	(2,210)	(1,953)
Marketable Securities, Debt, Fair Value	59,452	63,939
Cash and Cash Equivalents	47	26
Current Marketable Securities	14,451	16,027
Non-Current Marketable Securities	44,954	47,886
Municipal securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	355	412
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(7)	(7)
Marketable Securities, Debt, Fair Value	348	405
Cash and Cash Equivalents	0	0
Current Marketable Securities	189	190
Non-Current Marketable Securities	159	215
Mortgage- and asset-backed securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	25,313	24,595
Marketable Securities, Debt, Unrealized Gains	29	175
Marketable Securities, Debt, Unrealized Losses	(1,987)	(1,403)
Marketable Securities, Debt, Fair Value	23,355	23,367
Cash and Cash Equivalents	0	0
Current Marketable Securities	667	1,278
Non-Current Marketable Securities	$ 22,688	$ 22,089

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) $ in Billions	3 Months Ended	12 Months Ended
	Dec. 28, 2024 USD ($) Vendor Customer	Sep. 28, 2024 USD ($) Vendor
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Carrying amount of hedged term debt | $	$ 13.3	$ 13.5
Trade receivables | Credit concentration risk
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Number of customers that individually represented 10% or more of total trade receivables | Customer	2
Trade receivables | Credit concentration risk | Customer One
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Concentration risk, percentage	18%
Trade receivables | Credit concentration risk | Customer Two
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Concentration risk, percentage	11%
Trade receivables | Credit concentration risk | Cellular network carriers
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Concentration risk, percentage	33%	38%
Non-trade receivables | Credit concentration risk
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Number of vendors that individually represented 10% or more of total vendor non-trade receivables | Vendor	2	2
Non-trade receivables | Credit concentration risk | Vendor one
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Concentration risk, percentage	43%	44%
Non-trade receivables | Credit concentration risk | Vendor two
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Concentration risk, percentage	24%	23%
Hedges of foreign currency exposure associated with revenue and inventory purchases
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions	12 months
Hedges of foreign currency exposure associated with term debt
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions	18 years
Marketable debt securities other than mortgage- and asset-backed securities
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Between 1 and 5 years	85%
Between 5 and 10 years	11%
Greater than 10 years	4%
Mortgage- and asset-backed securities
Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Between 1 and 5 years	13%
Between 5 and 10 years	10%
Greater than 10 years	77%

Financial Instruments - Notiona

Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 28, 2024	Sep. 28, 2024
Derivatives designated as accounting hedges | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	$ 47,466	$ 64,069
Derivatives designated as accounting hedges | Interest rate contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	14,575	14,575
Derivatives not designated as accounting hedges | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	$ 96,150	$ 91,493

Condensed Consolidated Financ_3

Condensed Consolidated Financial Statement Details - Inventories (Details) - USD ($) $ in Millions	Dec. 28, 2024	Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Components	$ 2,792	$ 3,627
Finished goods	4,119	3,659
Total inventories	$ 6,911	$ 7,286

Condensed Consolidated Financ_4

Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Dec. 28, 2024	Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gross property, plant and equipment	$ 120,615	$ 119,128
Accumulated depreciation	(74,546)	(73,448)
Total property, plant and equipment, net	$ 46,069	$ 45,680

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($) $ in Millions	Dec. 28, 2024	Sep. 28, 2024
Debt Instrument [Line Items]
Commercial paper	$ 1,995	$ 9,967
Fixed-rate notes, aggregate carrying amount	94,800	96,700
Commercial paper
Debt Instrument [Line Items]
Commercial paper	2,000	10,000
Level 2
Debt Instrument [Line Items]
Fixed-rate notes, aggregate fair value	$ 82,700	$ 88,400

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) shares in Millions, $ in Billions	3 Months Ended
	Dec. 28, 2024 USD ($) shares
Stockholders' Equity Note [Abstract]
Number of shares repurchased (in shares) | shares	100
Amount of share repurchases | $	$ 23.3

Share-Based Compensation - Rest

Share-Based Compensation - Restricted Stock Unit Activity and Related Information (Details) - Restricted stock units shares in Thousands	3 Months Ended
	Dec. 28, 2024 $ / shares shares
Number of Restricted Stock Units
Beginning balance (in shares) | shares	163,326
RSUs granted (in shares) | shares	61,391
RSUs vested (in shares) | shares	(35,683)
RSUs canceled (in shares) | shares	(2,278)
Ending balance (in shares) | shares	186,756
Weighted-Average Grant-Date Fair Value Per RSU
Beginning balance (in dollars per share) | $ / shares	$ 158.73
RSUs granted (in dollars per share) | $ / shares	228.04
RSUs vested (in dollars per share) | $ / shares	147.36
RSUs canceled (in dollars per share) | $ / shares	174.77
Ending balance (in dollars per share) | $ / shares	$ 183.49

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - Restricted stock units - USD ($) $ in Billions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total vesting-date fair value of RSUs	$ 8.4	$ 7.7
Total unrecognized compensation cost related to outstanding RSUs	$ 29.2
Total unrecognized compensation cost related to outstanding RSUs, weighted-average recognition period	2 years 10 months 24 days

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based compensation expense	$ 3,286	$ 2,997
Income tax benefit related to share-based compensation expense	$ (1,332)	$ (1,235)

Segment Information and Geogr_3

Segment Information and Geographic Data - Information by Reportable Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Segment Reporting Information [Line Items]
Net sales	$ 124,300	$ 119,575
Operating income	42,832	40,373
Americas
Segment Reporting Information [Line Items]
Net sales	52,648	50,430
Operating income	21,509	20,357
Europe
Segment Reporting Information [Line Items]
Net sales	33,861	30,397
Operating income	14,607	12,711
Greater China
Segment Reporting Information [Line Items]
Net sales	18,513	20,819
Operating income	8,160	8,622
Japan
Segment Reporting Information [Line Items]
Net sales	8,987	7,767
Operating income	4,314	3,819
Rest of Asia Pacific
Segment Reporting Information [Line Items]
Net sales	10,291	10,162
Operating income	$ 4,584	$ 4,579

Segment Information and Geogr_4

Segment Information and Geographic Data - Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	$ 42,832	$ 40,373
Research and development expense	(8,268)	(7,696)
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	53,174	50,088
Segment reconciling items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Research and development expense	(8,268)	(7,696)
Corporate non-segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other corporate expenses, net	$ (2,074)	$ (2,019)